dermatan sulfate has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borsig, L; Kozlowski, EO; Pavao, MS | 1 |
| Mizumoto, S; Sugahara, K | 1 |
1 review(s) available for dermatan sulfate and B16 Melanoma
| Article | Year |
|---|---|
Glycosaminoglycans are functional ligands for receptor for advanced glycation end-products in tumors.
Topics: Animals; Antibodies; Antineoplastic Agents; Carcinoma, Lewis Lung; Chondroitin Sulfates; Dermatan Sulfate; Glucuronic Acid; Humans; Ligands; Lung; Melanoma, Experimental; Mice; Neoplasm Metastasis; Protein Interaction Mapping; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2013 |
1 other study(ies) available for dermatan sulfate and B16 Melanoma
| Article | Year |
|---|---|
Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Dermatan Sulfate; Humans; Inflammation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neoplasms, Experimental; Neutrophils; P-Selectin; Thrombosis; Urochordata | 2011 |